Chairs
- Robert L. Coleman (The Woodlands, TX, United States of America)
Introduction and first vote
Speakers
- Robert L. Coleman (The Woodlands, TX, United States of America)
The data absolutely support integration of HIPEC into primary ovarian cancer management (PRO)
Speakers
- Willemien Van Driel (Amsterdam, Netherlands)
HIPEC is not “IT” (CON)
Speakers
- Leslie Randall (Richmond, United States of America)
Second vote and conclusions
Speakers
- Robert L. Coleman (The Woodlands, TX, United States of America)